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The commercial Rapid Polymyxin NP test was evaluated to detect colistin-resistant Enterobacteriaceae. A total of
223 enterobacterial isolates corresponding to 136 resistant (including 38 MCR-like producers), 19
heteroresistant, and 78 colistin-susceptible isolates were tested. The test was performed according to the
manufacturer's instruction, and the color of the wells was read after 2 and 3 hours of incubation. The results
were compared with those of the homemade Rapid Polymyxin NP test, and manual broth microdilution
according to EUCAST guidelines was used as the reference method to determine the performance of the test.
Excellent performance of the commercial Rapid Polymyxin NP test was found with a very major error rate, a
major error rate, a sensitivity, and a speciﬁcity of 1.9%, 5.1%, 98.1%, and 94.9%, respectively. The performance of
the homemade Polymyxin NP test was similar, with a slightly better value for the very major error (1.2 %).
Polymyxins represent one of the few remaining treatment options
for treating carbapenemase-producing Enterobacteriaceae. The increas-
ing use of polymyxins is now associated with increasing isolation of
colistin-resistant isolates worldwide (Poirel et al., 2017). Since the iden-
tiﬁcation of the plasmid-mediated colistin resistance gene mcr-1, and
then more recently of other MCR-like encoding genes, controlling the
dissemination of colistin resistance has now become a major concern
(Poirel et al., 2017). Indeed, the fear is to isolate carbapenem- and
polymyxin-resistant isolates, therefore exhibiting pandrug resistance.
It becomes now mandatory to possess reliable and rapid diagnostic
techniques for determining polymyxin susceptibility.
The broth microdilution (BMD) technique that is time-consuming
(18 h) has been retained as the reference method for evaluating poly-
myxin susceptibility. A rapid test (Rapid Polymyxin NP test) has been
recently developed to detect colistin resistance in Enterobacteriaceae
within 2 hours (Nordmann et al., 2016a,b). This test is based on the
detection of the glucosemetabolism of Enterobacteriaceae upon culture
and differentiates colistin-susceptible from colistin-resistant isolates by
supplementing the growthmediumwith a given concentration of colis-
tin. An industrial version of this test is now available (ELITechGroup,
Puteaux, France). The objective of this study was to evaluate the per-
formance of this industrial Rapid Polymyxin NP test to detect colistin
resistance and heteroresistance in Enterobacteriaceae.
A collection of 233 enterobacterial isolates was tested using the
homemade and the industrial Rapid Polymyxin NP test. It included
136 colistin-resistant, 19 colistin-heteroresistant (Guerin et al., 2016;
Hjort et al., 2016), and 78 colistin-susceptible isolates, belonging to var-
ious enterobacterial species. Among the 136 colistin-resistant isolates,
10 belonged to bacterial species intrinsically resistant to colistin, 120
had been characterized for their acquired mechanisms of resistance
(chromosomally or plasmid encoded), and 6 isolates presented an
unknown mechanism of resistance (Table 1). Overall, resistance mech-
anisms corresponded to substitutions or truncations in the PmrA/PmrB
proteins, the PhoP/PhoQ regulatory proteins, and the MgrB protein. In
addition, 38 of the resistant isolates produced the plasmid-mediated
MCR-1, MCR-2, MCR-3, or MCR-4 determinants.
The homemade and industrial Polymyxin NP tests were both
performed by using a 3–3.5 McFarland bacterial suspension into 0.9%
NaCl as recommended (Nordmann et al., 2016a,b, and manufacturer
guidelines). Results were interpreted by 2 independent readers after 2
and 3 hours of incubation at 37 °C. A positive test corresponded to an
orange-to-yellow color change, whereas an orange color corresponded
to a negative test.
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Table 1
Features of the tested strain collection and comparative results between the homemade and commercialized Rapid Polymyxin NP tests.










R1583 P. vulgaris + + N16 Intrinsic This study
R2260 P. mirabilis + + N16 Intrinsic This study
R2556 P. mirabilis + + N16 Intrinsic This study
R1473 M. morganii + + N16 Intrinsic This study
R1474 M. morganii + + N16 Intrinsic This study
R1607 P. stuartii + + N16 Intrinsic This study
R2593 P. rettgeri + + N16 Intrinsic This study
R2594 P. rettgeri + + N16 Intrinsic This study
R1278 S. marcescens + + N16 Intrinsic This study
R2480 S. marcescens + + N16 Intrinsic This study
FR-06 K. pneumoniae + + 32 PmrA G53C (Nordmann et al., 2016a)
FR-07 K. pneumoniae + + 32 PmrA G53S (Nordmann et al., 2016a)
FR-08 K. pneumoniae + + 128 PmrA G53S (Nordmann et al., 2016a)
FR-09 K. pneumoniae + + 32 PmrB L17Q (Nordmann et al., 2016a)
FR-10 K. pneumoniae + + 16 PmrB T157P (Nordmann et al., 2016a)
FR-11 K. pneumoniae + + 32 PmrB T157P (Nordmann et al., 2016a)
FR-12 K. pneumoniae + + 16 PmrB T157P (Nordmann et al., 2016a)
FR-13 K. pneumoniae + + 32 PmrB T157P (Nordmann et al., 2016a)
FR-14 K. pneumoniae + + 32 PmrB T157P (Nordmann et al., 2016a)
FR-15 K. pneumoniae + + 16 PmrB T157P (Nordmann et al., 2016a)
FR-16 K. pneumoniae + + 128 PhoP D191Y and deletion of 25 nt (Nordmann et al., 2016a)
FR-17 K. pneumoniae + + N128 PhoQ R16C (Nordmann et al., 2016a)
FR-18 K. pneumoniae + + 32 MgrB W20R (Nordmann et al., 2016a)
FR-19 K. pneumoniae + + 32 MgrB M27K (Nordmann et al., 2016a)
FR-20 K. pneumoniae + + 64 MgrB C39Y (Nordmann et al., 2016a)
FR-22 K. pneumoniae + + 64 MgrB I45T (Nordmann et al., 2016a)
FR-23 K. pneumoniae + + 64 MgrB P46S (Nordmann et al., 2016a)
FR-24 K. pneumoniae + + 4 MgrB W47R (Nordmann et al., 2016a)
FR-25 K. pneumoniae + + 128 MgrB truncated (2 aa) (Nordmann et al., 2016a)
FR-26 K. pneumoniae + + 128 MgrB truncated (2 aa) (Nordmann et al., 2016a)
FR-27 K. pneumoniae + + 64 MgrB truncated (2 aa) (Nordmann et al., 2016a)
FR-28 K. pneumoniae + + 128 MgrB truncated (27 aa) (Nordmann et al., 2016a)
FR-31 K. pneumoniae + + 64 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-32 K. pneumoniae + + 64 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-33 K. pneumoniae + + 32 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-34 K. pneumoniae + + 64 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-35 K. pneumoniae + + 128 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-36 K. pneumoniae + + 128 MgrB truncated (29 aa) (Nordmann et al., 2016a)
FR-37 K. pneumoniae + + 32 MgrB truncated (32 aa) (Nordmann et al., 2016a)
FR-38 K. pneumoniae + + 32 MgrB truncated (46 aa) (Nordmann et al., 2016a)
FR-39 K. pneumoniae + + 64 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-40 K. pneumoniae + + 64 mgrB truncated by ISEcp1/blaCTX-M-15 (Nordmann et al., 2016a)
FR-41 K. pneumoniae + + 32 mgrB truncated by IS102-like (Nordmann et al., 2016a)
FR-42 K. pneumoniae + + N128 mgrB truncated by IS102-like (Nordmann et al., 2016a)
FR-43 K. pneumoniae + + 64 mgrB truncated by IS903b (Nordmann et al., 2016a)
FR-44 K. pneumoniae + + 64 mgrB truncated by IS2 (Nordmann et al., 2016a)
FR-45 K. pneumoniae + + 128 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-46 K. pneumoniae + + 64 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-47 K. pneumoniae + + 64 mgrB truncated by IS903b-like (Nordmann et al., 2016a)
FR-48 K. pneumoniae + + 128 mgrB truncated by IS903-like (Nordmann et al., 2016a)
FR-49 K. pneumoniae + + 64 mgrB truncated by IS5-like (Nordmann et al., 2016a)
FR-50 K. pneumoniae + + 16 mgrB truncated by IS5-like (Nordmann et al., 2016a)
FR-51 K. pneumoniae + + 64 mgrB truncated by IS5-like (Nordmann et al., 2016a)
FR-52 K. pneumoniae + + 128 mgrB truncated by IS5-like (Nordmann et al., 2016a)
FR-54 K. pneumoniae + + 128 mgrB truncated by ISKpn13 (Nordmann et al., 2016a)
FR-56 K. pneumoniae + + 64 mgrB truncated by ISKpn26-like (Nordmann et al., 2016a)
FR-58 K. pneumoniae + + 32 mgrB truncated by ISKpn26-like (Nordmann et al., 2016a)
FR-62 K. pneumoniae + + 64 mgrB truncated by IS903b (Nordmann et al., 2016a)
FR-63 K. pneumoniae + + 128 mgrB truncated by IS1R-like (Nordmann et al., 2016a)
FR-67 K. pneumoniae + + 128 mgrB truncated by ISKpn26-like (Nordmann et al., 2016a)
FR-68 K. pneumoniae + + 64 mgrB truncated by ISKpn14 (Nordmann et al., 2016a)
FR-69 K. pneumoniae + + 128 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-81 K. pneumoniae + + 64 Full mgrB gene deletion (Nordmann et al., 2016a)
FR-84 K. pneumoniae + + 128 Deletion nt 70 mgrB and substitution nt 73 (Nordmann et al., 2016a)
FR-89 K. pneumoniae + + N128 Deletion nt 23 to 33 mgrB (Nordmann et al., 2016a)
FR-90 K. pneumoniae + + 64 Deletion nt 30 et 31 mgrB (Nordmann et al., 2016a)
FR-87 K. pneumoniae + + 16 Deletion nt 100 mgrB (Nordmann et al., 2016a)
FR-30 K. pneumoniae + + N128 MgrB truncated (27 aa) (Nordmann et al., 2016a)
FR-53 K. pneumoniae + + 64 mgrB truncated by IS5-like (Nordmann et al., 2016a)
FR-55 K. pneumoniae + + N 128 mgrB truncated by ISKpn26-like (Nordmann et al., 2016a)
FR-57 K. pneumoniae + + 128 mgrB truncated by ISKpn26-like (Nordmann et al., 2016a)
FR-59 K. pneumoniae + + 32 mgrB truncated by IS903B (Nordmann et al., 2016a)


















FR-60 K. pneumoniae + + 128 mgrB ISKpn14 between +77 and +78 (Nordmann et al., 2016a)
FR-61 K. pneumoniae + + 128 mgrB duplication 19 nt between +84 and +85 (Nordmann et al., 2016a)
FR-64 K. pneumoniae + + 64 mgrB truncated by IS903b-like (Nordmann et al., 2016a)
FR-65 K. pneumoniae + + 8 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-66 K. pneumoniae + + 32 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-70 K. pneumoniae + + 128 mgrB truncated by IS10R (Nordmann et al., 2016a)
FR-71 K. pneumoniae + + 64 mgrB truncated by ISKpn14 (Nordmann et al., 2016a)
FR-72 K. pneumoniae + + 64 mgrB truncated by ISKpn14 (Nordmann et al., 2016a)
FR-73 K. pneumoniae + + 64 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-74 K. pneumoniae + + 128 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-75 K. pneumoniae + + 64 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-76 K. pneumoniae + + 32 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-77 K. pneumoniae + + 32 mgrB truncated by ISKpn14-like (Nordmann et al., 2016a)
FR-78 K. pneumoniae + + 32 mgrB truncated by IS1R (Nordmann et al., 2016a)
FR-79 K. pneumoniae + + 16 Full mgrB gene deletion (Nordmann et al., 2016a)
FR-80 K. pneumoniae + + N 128 Full mgrB gene deletion (Nordmann et al., 2016a)
FR-82 K. pneumoniae + + 64 Full mgrB gene deletion (Nordmann et al., 2016a)
FR-83 K. pneumoniae + + 32 Deletion nt 23 mgrB (Nordmann et al., 2016a)
FR-85 K. pneumoniae + + 64 Deletion nt 74 mgrB (Nordmann et al., 2016a)
FR-86 K. pneumoniae + + 64 Deletion nt 100 mgrB (Nordmann et al., 2016a)
FR-93 E. coli + + 4 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-94 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-95 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-96 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-97 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-98 E. coli + + 8 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
FR-99 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
Af48 E. coli + + 8 Plasmid-mediated mcr-1 gene Poirel et al., 2016
CDF1 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
CDF2 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016a)
CDF6 E. coli + + 16 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017b)
CDF8 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017b)
AGU E. coli + + 8 Plasmid-mediated mcr-1 gene This study
DJE E. coli + + 8 Plasmid-mediated mcr-1 gene This study
S115 E. coli + + 16 Plasmid-mediated mcr-1 gene (Nordmann et al., 2016b)
P4 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
P26 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B4 E. coli + + 4 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B8 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B9 E. coli + + 16 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B12 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B15 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B18 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B19 E. coli + + 16 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B20 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B22 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B47 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B50 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
C2729 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
C2730 E. coli + + 8 Plasmid-mediated mcr-1 gene (Kieffer et al., 2017a)
B31K K. pneumoniae + + 16 Plasmid-mediated mcr-1 gene This study
P26 K. pneumoniae + + 8 Plasmid-mediated mcr-1 gene This study
C2728 K. pneumoniae + + 16 Plasmid-mediated mcr-1 gene This study
C2731 S. enterica + + 8 Plasmid-mediated mcr-1 gene This study
C2732 S. enterica + + 16 Plasmid-mediated mcr-1 gene This study
R2812 E. coli + + 4 Plasmid-mediated mcr-2 gene (Xavier et al., 2016)
R3181 E. coli + + 4 Plasmid-mediated mcr-3–like gene This study
S136 S. enterica + + 4 Plasmid-mediated mcr-4–like gene This study
FR-119 E. coli − − 8 Unknown This study
FR-109 K. pneumoniae + + 64 Unknown This study
FR-115 K. pneumoniae + + 64 Unknown This study
FR-103 K. pneumoniae + + 4 Unknown This study
FR-118 K. pneumoniae + + 4 Unknown This study
FR-121 E. coli + + 4 Unknown This study
Heteroresistant isolates
DA27007 S. enterica + + 4 Chromosomal ampliﬁcation of pmrD gene (Hjort et al., 2016)
DA33039 S. enterica + + 4 Chromosomal ampliﬁcation of pmrD gene (Hjort et al., 2016)
R2914 E. cloacae + + N256 Cluster XI (Guerin et al., 2016)
R2915 E. cloacae + + N256 Cluster I (Guerin et al., 2016)
R2917 E. cloacae + + (3h) N256 Cluster I (Guerin et al., 2016)
R2919 E. cloacae + + 256 Cluster II (Guerin et al., 2016)
R2922 E. cloacae + − 16 Cluster IV (Guerin et al., 2016)
R2923 E. cloacae − − 16 Cluster IV (Guerin et al., 2016)
R2928 E. cloacae + + 64 Cluster VII (Guerin et al., 2016)


















R2932 E. cloacae + + (3 h) 256 Cluster IX (Guerin et al., 2016)
R2933 E. cloacae + + (3 h) 64 Cluster IX (Guerin et al., 2016)
R2936 E. cloacae + + 128 Cluster XI (Guerin et al., 2016)
R2938 E. cloacae + + N256 Cluster XII (Guerin et al., 2016)
R2939 E. cloacae + + 128 Cluster XII (Guerin et al., 2016)
R2945 E. cloacae + + 256 Cluster XI (Guerin et al., 2016)
R2946 E. cloacae + + 16 Cluster XI (Guerin et al., 2016)
R2947 E. cloacae + + 256 Cluster XI (Guerin et al., 2016)
R2950 E. cloacae + + 16 Cluster XI (Guerin et al., 2016)
Susceptible isolates
ATCC 25922 E. coli − − 0.125 Wild-type Reference strain
FR-180 K. pneumoniae + + 1 NA (Nordmann et al., 2016a)
FR-181 K. pneumoniae + + 2 NA (Nordmann et al., 2016a)
FR-182 K. pneumoniae + + 2 NA (Nordmann et al., 2016a)
C451 E. coli − − 1 NA This study
C889 K. pneumoniae − − 2 NA This study
C861 K. pneumoniae + + 2 NA This study
FR-165 K. pneumoniae − − 1 NA (Nordmann et al., 2016a)
C349 K. pneumoniae − − b1 NA This study
C352 E. coli − − b1 NA This study
C353 E. coli − − b1 NA This study
C355 E. coli − − b1 NA This study
C358 E. coli − − b1 NA This study
C360 E. coli − − b1 NA This study
C361 E. coli − − b1 NA This study
C468 E. coli − − b1 NA This study
C469 E. coli − − b1 NA This study
C470 C. koseri − − b1 NA This study
C472 E. aerogenes − − 0.25 NA This study
C474 C. koseri − − b1 NA This study
C481 K. oxytoca − − b1 NA This study
C490 K. pneumoniae − − b1 NA This study
C508 K. pneumoniae − − b1 NA This study
C509 K. pneumoniae − − b1 NA This study
C512 E. aerogenes − − b1 NA This study
C519 C. koseri − − b1 NA This study
C524 K. pneumoniae − − b1 NA This study
C533 K. pneumoniae − − b1 NA This study
C539 C. koseri − − b1 NA This study
C548 E. aerogenes − − b1 NA This study
C554 K. pneumoniae − − b1 NA This study
C597 K. pneumoniae − − b1 NA This study
C607 K. pneumoniae − − b1 NA This study
C632 E. aerogenes − − b1 NA This study
C635 C. koseri − − b1 NA This study
C867 C. koseri − − b1 NA This study
C901 K. pneumoniae − − 0.5 NA This study
C914 K. pneumoniae − − 0.125 NA This study
C937 C. koseri − − b1 NA This study
C1029 K. oxytoca − − b1 NA This study
C1033 E. cloacae − − b1 NA This study
C1066 E. coli − − b1 NA This study
C1077 E. cloacae − − b1 NA This study
C1082 K. oxytoca − − b1 NA This study
C1085 C. koseri − − b1 NA This study
C1087 K. oxytoca − − b1 NA This study
C1216 E. cloacae − − b1 NA This study
C1221 E. aerogenes − − b1 NA This study
C1231 K. oxytoca − − b1 NA This study
C1234 K. oxytoca − − b1 NA This study
C1285 E. aerogenes − − b1 NA This study
C1288 E. aerogenes − − b1 NA This study
C1293 E. aerogenes − − b1 NA This study
C1397 K. oxytoca − − b1 NA This study
C1591 C. freundii − − b1 NA This study
C1637 E. cloacae − − b1 NA This study
C1664 K. oxytoca − − b1 NA This study
C1671 C. freundii − − b1 NA This study
C1703 E. cloacae − − b1 NA This study
C1753 E. cloacae − − b1 NA This study
C1877 C. freundii − − b1 NA This study
C2155 C. freundii − − b1 NA This study
C2635 Salmonella spp. − − b1 NA This study
C3690 C. freundii − − b1 NA This study








MICs of colistin were determined in parallel by BMD using cation-
adjusted Muller Hinton broth (Bio-Rad, Cressier, Switzerland), and
Escherichia coli ATCC 25922 was used as control strain. In case of “skip
wells” (likely indicating heteroresistance), MICs were determined by
considering the well with the highest concentration in which growth
was observed, regardless the clear wells (Guerin et al., 2016). Isolates
with MICs of colistin N2 μg/mL were considered as resistant, whereas
isolates showing aMIC ≤2 μg/mLwere considered as susceptible. Results
of the 2 Polymyxin NP tests read after 3 hours of incubation were com-
paredwith those of the BMD. Errors were ranked as follows: verymajor
error (VME) deﬁned by isolates categorized as susceptible using the
marketed panel but resistant by the BMD reference method (false-sus-
ceptibility result), and major error (ME) deﬁned by isolates categorized
as resistant using themarketed panel but susceptible by the BMD refer-
ence method (false-resistant result).
Among the susceptible isolates tested (n = 78), 4 ME (5.1%) were
detected with both tests giving a speciﬁcity of 94.9% (74/78). Those
false-positive results corresponded to isolates having MICs of colistin
close to the breakpoint value (i.e., 1–2 μg/mL).
Among the resistant isolates (n = 155), 2 VME (1.2%) and 3 VME
(1.9%) were detected with both the homemade and of the industrial
Rapid Polymyxin NP tests, giving sensitivity rates of 98.7% (153/155)
and 98.1% (152/155), respectively. Experiments were reproduced
twice with distinct reading persons and results showed perfect agree-
ment. A single E. coli with an unknown mechanism of resistance was
not detected by using both tests. A single and 2 heteroresistant Entero-
bacter cloacae isolates were not detected with the homemade and of
the industrial Rapid Polymyxin NP tests, respectively. Noteworthy, 3
heteroresistant E. cloacae isolates were detected after 2 hours of incuba-
tionwith the homemade test, whereas theywere detected after 3 hours
of incubation with the industrial test. The performance of the home-
made testwas therefore quite equivalent to the industrial test for detec-
tion of colistin heteroresistance. Such detection is challenging because
most of the routine methods (Etest, Vitek-2 automated system) give
false-susceptible results for such isolates (Poirel et al., 2017). Recently,
an evaluation of the homemade Rapid Polymyxin NP test for detection
of colistin heteroresistance in Enterobacter spp. was performed, using
a collection of 25 isolates, and a low sensitivity (25%) was actually
found (Simar et al., 2017). Such difference of results remains unex-
plained, but it is worth highlighting that the strains tested were differ-
ent. Further studies performed in different laboratories will be needed
to evaluate the reliability of the Polymyxin NP tests to detect colistin
heteroresistance.
Noteworthy, all the 38 isolates producing a plasmid-mediated colis-
tin resistance determinant (MCR-1 to MCR-4) were perfectly detected
by the 2 methods within 2 hours.
To conclude, the homemade and the industrial Polymyxin NP tests
showed high sensitivity (98.1%–98.7%) and speciﬁcity (94.9%) for
detection of colistin resistance in Enterobacteriaceae, regardless of the
resistance mechanisms. Those tests therefore possess the potential to
be reliable tools for screening colistin-resistant Enterobacteriaceae in
clinical laboratories.
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Table 1 (continued)









R281 E. asburiae − − b1 NA This study
R1414 C. freundii − − b1 NA This study
R1415 C. freundii − − b1 NA This study
R1416 C. freundii − − b1 NA This study
R1527 S. Concord − − b1 NA This study
R1528 Salmonella spp. − − b1 NA This study
R1529 S. Isangi − − b1 NA This study
C362 K. pneumoniae − − 0.125 NA This study
C367 K. pneumoniae − − 0.125 NA This study
C370 K. pneumoniae − − 0.125 NA This study
C382 K. pneumoniae − − 0.125 NA This study
C383 K. pneumoniae − − 0.125 NA This study
C609 K. pneumoniae − − 0.125 NA This study
C643 K. pneumoniae − − 0.125 NA This study
a Isolates with discordant results are shaded.
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